HM Payson & Co’s Incyte INCY Stock Holding History

HM Payson & Co’s Portfolio INCY Stock Details INCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10	Closed	-$661	–	1090
2024 Q3	$661	Buy	+10	New	+$638	﹤0.01%	1052
2019 Q3	–	Sell	-150	Closed	-$13K	–	957
2019 Q2	$13K	Buy	+150	New	+$12K	﹤0.01%	788

Other funds holding INCY

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

HM Payson & Co's INCY Position: Q4 2024 in Review

HM Payson & Co sold out of Incyte (INCY) in Q4 2024, closing a stake of 10 shares — an estimated $661 sold.

HM Payson & Co first reported a position in INCY in Q2 2019 and held it in 2 quarters. The position peaked at $13K in Q2 2019. 649 funds tracked by Wall St. Rank hold INCY as of Q4 2024.

HM Payson & Co reported no remaining Incyte position as of Q4 2024 after selling out during the quarter.
HM Payson & Co sold 10 Incyte shares in Q4 2024, an estimated $661.
HM Payson & Co first reported a position in Incyte in Q2 2019 and held it in 2 quarters.
HM Payson & Co's Incyte position peaked at $13K in Q2 2019.
649 funds tracked by Wall St. Rank held Incyte as of Q4 2024.

Based on HM Payson & Co's 13F filing for Q4 2024, filed 7 Feb 2025.